Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life

Background Although health‐related quality of life (HRQoL) recovers after surgery for oesophageal cancer in most long‐term survivors, one in seven patients experiences a deterioration in HRQoL for reasons yet unknown. The aim of this study was to assess whether co‐morbidities diagnosed after surgery...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery 2016-11, Vol.103 (12), p.1665-1675
Hauptverfasser: Backemar, L., Wikman, A., Djärv, T., Johar, A., Lagergren, P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1675
container_issue 12
container_start_page 1665
container_title British journal of surgery
container_volume 103
creator Backemar, L.
Wikman, A.
Djärv, T.
Johar, A.
Lagergren, P.
description Background Although health‐related quality of life (HRQoL) recovers after surgery for oesophageal cancer in most long‐term survivors, one in seven patients experiences a deterioration in HRQoL for reasons yet unknown. The aim of this study was to assess whether co‐morbidities diagnosed after surgery influence recovery of HRQoL. Methods Patients who underwent surgery for cancer of the oesophagus or gastro‐oesophageal junction in Sweden between 2001 and 2005 were included. HRQoL was assessed by means of the European Organization for Research and Treatment of Cancer QLQ‐C30 and QLQ‐OES18 questionnaires. Repeated‐measures ANOVA was used to assess mean differences in HRQoL scores between three co‐morbidity status groups (healthy, stable and increased) over time. Probabilities of deterioration in HRQoL were calculated based on marginal probabilities from logistic regression models. Results At 5 years' follow‐up, 153 (24·8 per cent) of 616 patients were alive and 137 responded to at least two of three questionnaires. The healthy and increased co‐morbidity groups showed deterioration in almost all aspects of HRQoL at 6 months after surgery compared with baseline. The increased co‐morbidity group also deteriorated in several aspects from 3 to 5 years after surgery. Patients with an increase in co‐morbidity did not have a significantly increased probability of deterioration in HRQoL over time compared with healthy or stable patients, except with respect to cognitive function, loss of appetite, choking and coughing. Conclusion Patients with an increase in co‐morbidities after oesophagectomy experience long‐term deterioration in HRQoL. Deterioration in quality of life with increasing comorbidity
doi_str_mv 10.1002/bjs.10248
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_502955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834998170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5268-6e8de89ae7dcd6cf3a3ba5d080208e682148f68faae9c3c823aa7f8975abe31f3</originalsourceid><addsrcrecordid>eNp90ktvEzEQAGALUdFQOPAH0EpcOLCtH-vHHkuAQtUCohAuSNbs7mzidBOn9i4l_x6nCamEBCePx59Hfgwhzxg9ZpTyk2oeU8AL84CMmFAy50yZh2REKdU5E1wckscxzillgkr-iBxyLQtZajMiP8Y-X_hQucb16wzaHkPmMfrVDKYIXVbDsk6pOIQphgSWTRaw9j83E99ms2T6WR6wgx6b7GaAblMnrXSuxSfkoIUu4tPdeES-vXv7dfw-v_h09mF8epHXkiuTKzQNmhJQN3Wj6laAqEA21FBODSrDWWFaZVoALGtRGy4AdGtKLaFCwVpxRPJt3XiLq6Gyq-AWENbWg7O71HWK0ErKSymTf_VP_8ZNTq0PUzsMtqBUGpb4yy1fBX8zYOztwsUauw6W6IdomRFFWRqmaaIv_qJzP4RlurzlVEgtmaTqf2pTq9BGKZHU850aqgU2-1P--bwETrbg1nW43q8zajddYVNX2LuusK_Pr-6C-4dyscdf-x0Qrq3SQkv7_eOZnVxOrsrJl8_2XPwG14y4-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834478663</pqid></control><display><type>article</type><title>Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Backemar, L. ; Wikman, A. ; Djärv, T. ; Johar, A. ; Lagergren, P.</creator><creatorcontrib>Backemar, L. ; Wikman, A. ; Djärv, T. ; Johar, A. ; Lagergren, P.</creatorcontrib><description>Background Although health‐related quality of life (HRQoL) recovers after surgery for oesophageal cancer in most long‐term survivors, one in seven patients experiences a deterioration in HRQoL for reasons yet unknown. The aim of this study was to assess whether co‐morbidities diagnosed after surgery influence recovery of HRQoL. Methods Patients who underwent surgery for cancer of the oesophagus or gastro‐oesophageal junction in Sweden between 2001 and 2005 were included. HRQoL was assessed by means of the European Organization for Research and Treatment of Cancer QLQ‐C30 and QLQ‐OES18 questionnaires. Repeated‐measures ANOVA was used to assess mean differences in HRQoL scores between three co‐morbidity status groups (healthy, stable and increased) over time. Probabilities of deterioration in HRQoL were calculated based on marginal probabilities from logistic regression models. Results At 5 years' follow‐up, 153 (24·8 per cent) of 616 patients were alive and 137 responded to at least two of three questionnaires. The healthy and increased co‐morbidity groups showed deterioration in almost all aspects of HRQoL at 6 months after surgery compared with baseline. The increased co‐morbidity group also deteriorated in several aspects from 3 to 5 years after surgery. Patients with an increase in co‐morbidity did not have a significantly increased probability of deterioration in HRQoL over time compared with healthy or stable patients, except with respect to cognitive function, loss of appetite, choking and coughing. Conclusion Patients with an increase in co‐morbidities after oesophagectomy experience long‐term deterioration in HRQoL. Deterioration in quality of life with increasing comorbidity</description><identifier>ISSN: 0007-1323</identifier><identifier>ISSN: 1365-2168</identifier><identifier>EISSN: 1365-2168</identifier><identifier>DOI: 10.1002/bjs.10248</identifier><identifier>PMID: 27545978</identifier><identifier>CODEN: BJSUAM</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adenocarcinoma - mortality ; Adenocarcinoma - surgery ; Adult ; Aged ; Cancer ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - surgery ; Comorbidity ; Esophageal cancer ; Esophageal Neoplasms - mortality ; Esophageal Neoplasms - surgery ; Esophagectomy - mortality ; Esophagogastric Junction - surgery ; Female ; Humans ; Male ; Middle Aged ; Morbidity ; Quality of Life ; Surgery ; Sweden - epidemiology</subject><ispartof>British journal of surgery, 2016-11, Vol.103 (12), p.1665-1675</ispartof><rights>2016 BJS Society Ltd Published by John Wiley &amp; Sons Ltd</rights><rights>2016 BJS Society Ltd Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2016 BJS Society Ltd. Published by John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5268-6e8de89ae7dcd6cf3a3ba5d080208e682148f68faae9c3c823aa7f8975abe31f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbjs.10248$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbjs.10248$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27545978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-400581$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:134651475$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Backemar, L.</creatorcontrib><creatorcontrib>Wikman, A.</creatorcontrib><creatorcontrib>Djärv, T.</creatorcontrib><creatorcontrib>Johar, A.</creatorcontrib><creatorcontrib>Lagergren, P.</creatorcontrib><title>Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life</title><title>British journal of surgery</title><addtitle>Br J Surg</addtitle><description>Background Although health‐related quality of life (HRQoL) recovers after surgery for oesophageal cancer in most long‐term survivors, one in seven patients experiences a deterioration in HRQoL for reasons yet unknown. The aim of this study was to assess whether co‐morbidities diagnosed after surgery influence recovery of HRQoL. Methods Patients who underwent surgery for cancer of the oesophagus or gastro‐oesophageal junction in Sweden between 2001 and 2005 were included. HRQoL was assessed by means of the European Organization for Research and Treatment of Cancer QLQ‐C30 and QLQ‐OES18 questionnaires. Repeated‐measures ANOVA was used to assess mean differences in HRQoL scores between three co‐morbidity status groups (healthy, stable and increased) over time. Probabilities of deterioration in HRQoL were calculated based on marginal probabilities from logistic regression models. Results At 5 years' follow‐up, 153 (24·8 per cent) of 616 patients were alive and 137 responded to at least two of three questionnaires. The healthy and increased co‐morbidity groups showed deterioration in almost all aspects of HRQoL at 6 months after surgery compared with baseline. The increased co‐morbidity group also deteriorated in several aspects from 3 to 5 years after surgery. Patients with an increase in co‐morbidity did not have a significantly increased probability of deterioration in HRQoL over time compared with healthy or stable patients, except with respect to cognitive function, loss of appetite, choking and coughing. Conclusion Patients with an increase in co‐morbidities after oesophagectomy experience long‐term deterioration in HRQoL. Deterioration in quality of life with increasing comorbidity</description><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Cancer</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Comorbidity</subject><subject>Esophageal cancer</subject><subject>Esophageal Neoplasms - mortality</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophagectomy - mortality</subject><subject>Esophagogastric Junction - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Quality of Life</subject><subject>Surgery</subject><subject>Sweden - epidemiology</subject><issn>0007-1323</issn><issn>1365-2168</issn><issn>1365-2168</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90ktvEzEQAGALUdFQOPAH0EpcOLCtH-vHHkuAQtUCohAuSNbs7mzidBOn9i4l_x6nCamEBCePx59Hfgwhzxg9ZpTyk2oeU8AL84CMmFAy50yZh2REKdU5E1wckscxzillgkr-iBxyLQtZajMiP8Y-X_hQucb16wzaHkPmMfrVDKYIXVbDsk6pOIQphgSWTRaw9j83E99ms2T6WR6wgx6b7GaAblMnrXSuxSfkoIUu4tPdeES-vXv7dfw-v_h09mF8epHXkiuTKzQNmhJQN3Wj6laAqEA21FBODSrDWWFaZVoALGtRGy4AdGtKLaFCwVpxRPJt3XiLq6Gyq-AWENbWg7O71HWK0ErKSymTf_VP_8ZNTq0PUzsMtqBUGpb4yy1fBX8zYOztwsUauw6W6IdomRFFWRqmaaIv_qJzP4RlurzlVEgtmaTqf2pTq9BGKZHU850aqgU2-1P--bwETrbg1nW43q8zajddYVNX2LuusK_Pr-6C-4dyscdf-x0Qrq3SQkv7_eOZnVxOrsrJl8_2XPwG14y4-g</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Backemar, L.</creator><creator>Wikman, A.</creator><creator>Djärv, T.</creator><creator>Johar, A.</creator><creator>Lagergren, P.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>K9.</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope></search><sort><creationdate>201611</creationdate><title>Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life</title><author>Backemar, L. ; Wikman, A. ; Djärv, T. ; Johar, A. ; Lagergren, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5268-6e8de89ae7dcd6cf3a3ba5d080208e682148f68faae9c3c823aa7f8975abe31f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Cancer</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Comorbidity</topic><topic>Esophageal cancer</topic><topic>Esophageal Neoplasms - mortality</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophagectomy - mortality</topic><topic>Esophagogastric Junction - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Quality of Life</topic><topic>Surgery</topic><topic>Sweden - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Backemar, L.</creatorcontrib><creatorcontrib>Wikman, A.</creatorcontrib><creatorcontrib>Djärv, T.</creatorcontrib><creatorcontrib>Johar, A.</creatorcontrib><creatorcontrib>Lagergren, P.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>British journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Backemar, L.</au><au>Wikman, A.</au><au>Djärv, T.</au><au>Johar, A.</au><au>Lagergren, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life</atitle><jtitle>British journal of surgery</jtitle><addtitle>Br J Surg</addtitle><date>2016-11</date><risdate>2016</risdate><volume>103</volume><issue>12</issue><spage>1665</spage><epage>1675</epage><pages>1665-1675</pages><issn>0007-1323</issn><issn>1365-2168</issn><eissn>1365-2168</eissn><coden>BJSUAM</coden><abstract>Background Although health‐related quality of life (HRQoL) recovers after surgery for oesophageal cancer in most long‐term survivors, one in seven patients experiences a deterioration in HRQoL for reasons yet unknown. The aim of this study was to assess whether co‐morbidities diagnosed after surgery influence recovery of HRQoL. Methods Patients who underwent surgery for cancer of the oesophagus or gastro‐oesophageal junction in Sweden between 2001 and 2005 were included. HRQoL was assessed by means of the European Organization for Research and Treatment of Cancer QLQ‐C30 and QLQ‐OES18 questionnaires. Repeated‐measures ANOVA was used to assess mean differences in HRQoL scores between three co‐morbidity status groups (healthy, stable and increased) over time. Probabilities of deterioration in HRQoL were calculated based on marginal probabilities from logistic regression models. Results At 5 years' follow‐up, 153 (24·8 per cent) of 616 patients were alive and 137 responded to at least two of three questionnaires. The healthy and increased co‐morbidity groups showed deterioration in almost all aspects of HRQoL at 6 months after surgery compared with baseline. The increased co‐morbidity group also deteriorated in several aspects from 3 to 5 years after surgery. Patients with an increase in co‐morbidity did not have a significantly increased probability of deterioration in HRQoL over time compared with healthy or stable patients, except with respect to cognitive function, loss of appetite, choking and coughing. Conclusion Patients with an increase in co‐morbidities after oesophagectomy experience long‐term deterioration in HRQoL. Deterioration in quality of life with increasing comorbidity</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>27545978</pmid><doi>10.1002/bjs.10248</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1323
ispartof British journal of surgery, 2016-11, Vol.103 (12), p.1665-1675
issn 0007-1323
1365-2168
1365-2168
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_502955
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current)
subjects Adenocarcinoma - mortality
Adenocarcinoma - surgery
Adult
Aged
Cancer
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - surgery
Comorbidity
Esophageal cancer
Esophageal Neoplasms - mortality
Esophageal Neoplasms - surgery
Esophagectomy - mortality
Esophagogastric Junction - surgery
Female
Humans
Male
Middle Aged
Morbidity
Quality of Life
Surgery
Sweden - epidemiology
title Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A59%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Co-morbidity%20after%20oesophageal%20cancer%20surgery%20and%20recovery%20of%20health-related%20quality%20of%20life&rft.jtitle=British%20journal%20of%20surgery&rft.au=Backemar,%20L.&rft.date=2016-11&rft.volume=103&rft.issue=12&rft.spage=1665&rft.epage=1675&rft.pages=1665-1675&rft.issn=0007-1323&rft.eissn=1365-2168&rft.coden=BJSUAM&rft_id=info:doi/10.1002/bjs.10248&rft_dat=%3Cproquest_swepu%3E1834998170%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834478663&rft_id=info:pmid/27545978&rfr_iscdi=true